NDC 70428-011-11 - Qbrexza
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70428-011
- Requested NDC
- 70428-011-11
- Package NDCs from labels
- 70428-011-11, 70428-011-12
- Manufacturer
- Journey Medical Corporation | Aphena Pharma Solutions, LLC
- Effective date
- 2022-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Qbrexza - Journey Medical Corporation | Aphena Pharma Solutions, LLC | Journey Medical Corporation | Aphena Pharma Solutions, LLC | 2022-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70428-011-11 | EA - Each | 70428-011 | 5ddccef4-837c-4d64-8e86-b7a9966f6b23 | 1 | 2019-04-11 |
| 70428-011-12 | EA - Each | 70428-011 | b1bc7828-63b3-4737-9b80-7bdbb6859238 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Qbrexza | GLYCOPYRRONIUM | Journey Medical Corporation | 5b372650-e56e-47a5-93e2-c0c292017059 | 2026-05-21 | Warnings, Adverse reactions | NDA210361 1PVF6JLU7B |
| c56af57e-1ebb-4507-9474-11acdd6ca2b5 | 6b985380-1256-4fb3-b89a-6df2c6a6d12e | 2022-01-17 | Warnings, Adverse reactions | c56af57e-1ebb-4507-9474-11acdd6ca2b5 6b985380-1256-4fb3-b89a-6df2c6a6d12e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.